Achieve Life Sciences, Inc.

NASDAQ: ACHV · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCCIK 0000949858Reports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

37D

FH 34DQ 32GM —SS 71

v0.1 · 55/100 weight · provisional

↑ listing tenure, market scale · ↓ Piotroski F, disclosure history

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$54.6M

Employees

Market cap

$657.0M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02019

Net income-$54.6M-$54.6M2025

Total assets$41.8M$41.8M2025

Liabilities$20.3M$20.3M2025

Equity$21.5M$21.5M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Achieve Life Sciences, Inc. booked $0 in FY2019 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Esperion Therapeutics, Inc.60C Relmada Therapeutics, Inc.37D Monopar Therapeutics Inc.59C Annexon, Inc.——

Key facts

CEORichard A. Stewart

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeNASDAQ: ACHV

Employees25

IPO date1995-10-12

Latest filings

8-K2026-07-06 DEF 14A2026-06-08 8-K2026-06-02 10-Q2026-05-12 8-K2026-05-12 8-K2026-04-16 8-K2026-03-24 10-K2026-03-24

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.